The path to Hydrocortisone-17-Butyrate highlights how science responds to real medical needs. Decades ago, dermatology struggled with crude steroid formulations that irritated skin as much as they helped it. Scientists saw this and pushed to modify natural hydrocortisone, aiming for localized power and fewer side effects. By attaching a butyrate group at the 17th carbon, researchers tailored the molecule to nestle better into the skin and deliver anti-inflammatory action right where doctors wanted it. This tweak didn’t just make theoretical sense; clinical experience showed fewer flare-ups, less skin thinning, and improved patient comfort. Watching the evolution of topical steroids from broad, harsh tools into nuanced, safer options like Hydrocortisone-17-Butyrate reminds us that medical innovation starts with real-world challenges, not abstract theory.
As a medication, Hydrocortisone-17-Butyrate finds its place in creams, ointments, and lotions. Pharmacy shelves stock this compound because it brings reliable relief to eczema, psoriasis, and allergic rashes. It stands stronger than plain hydrocortisone, but remains milder than the most potent steroids. This middle ground matters. People use it when over-the-counter hydrocortisone falls short, yet hesitate to jump into higher-risk corticosteroids. Clinical guidelines recommend Hydrocortisone-17-Butyrate for moderate inflammatory skin conditions—especially in patients sensitive to stronger treatments, such as children or those with delicate facial skin.
Hydrocortisone-17-Butyrate appears as a white or slightly off-white crystalline powder. It doesn’t dissolve in water but mixes well with common fatty bases—a property that suits topical medication. With a molecular formula of C25H36O6 and a molecular weight just above 432, the molecule features subtle steroid backbone tweaks scientists designed for better skin penetration and slower breakdown. Its stability under normal storage conditions keeps it practical for pharmacies and clinics alike. Understanding these basics, one can see why formulators rely on it when they need a corticosteroid that won’t vanish or irritate.
Packaging and labeling come with specific requirements under both national pharmacopoeias and international regulatory bodies. Labels must state the compound’s name, concentration (often at 0.1%), lot number, manufacturing date, and storage conditions. Impurities and related substances receive strict upper limits. Pharmacies need to keep it away from direct sunlight, storing it between 2°C and 30°C, never freezing it. Labels include warnings about using the product on broken skin, in the eyes, or for extended periods. Clear labeling, based on years in the field, ensures both patients and health care workers avoid mishaps—from accidental overuse to inappropriate application.
Making Hydrocortisone-17-Butyrate combines organic chemistry finesse with pharmaceutical scale-up. Starting from core hydrocortisone, chemists add a butyrate group to the 17-hydroxyl group through esterification. This process involves reacting hydrocortisone with butyric anhydride or butyryl chloride in the presence of solvents and mild bases. Experienced hands know how sensitive the reaction is to moisture, temperature, and pH—too much variation, and yield or purity drop fast. In the lab, vigilance makes the difference between sharp, pharmacopoeial-grade material and useless waste.
Researchers continue to tweak the molecule. The basic modification—attaching butyrate at the 17 position—built a new profile for the base steroid. Some teams explore further esterifications or substitutions at other positions, chasing finer control over tissue penetration or metabolic half-life. Analytical chemists run chromatographic and spectrometric assays to confirm purity and to trace even tiny byproducts. Each modification goes through careful stress testing to predict how the material will behave under real-world conditions, including exposure to light, oxygen, and sweat.
On the label, Hydrocortisone-17-Butyrate appears under several trade names and synonyms. In some regions, it's marketed as Locoid, Altoid, or Hydrocortistone. Pharmacists know to check both generic and branded names to avoid confusion and dosing errors. Confusion between this compound and other hydrocortisone esters has led to prescription mistakes in the past, so clear nomenclature—rooted in both chemistry and regulatory tradition—protects patients.
Strict handling protocols protect everyone involved—from pharmaceutical staff mixing bulk material to patients applying a dab to irritated skin. These rules come from hard experience. Skin absorption rates mean excess application or misuse leads to systemic side effects. Manufacturing plants train employees to wear gloves, eye shields, and masks when handling the powder. Dispensers follow checklists drawn from regulatory standards to prevent batch contamination. Doctors warn patients about potential side effects: thinning skin, stretch marks, allergic reactions, and—especially after prolonged use—suppression of the body’s natural steroid production.
Hydrocortisone-17-Butyrate rides the edge between everyday care and specialist use. Parents rely on it to take the sting out of a child’s flare-up. Elderly patients see it as a way to control chronic rashes without the risk profile of super-strength alternatives. In hospitals and private practice, physicians place Hydrocortisone-17-Butyrate among their go-to options for conditions ranging from atopic dermatitis to contact allergies. Its milder strength allows longer or repeated courses, especially on sensitive or hard-to-treat skin. Practical experience matches clinical trial data—successful use requires following clear medical advice, careful dose control, and steady monitoring.
Research on Hydrocortisone-17-Butyrate spans chemistry labs, dermatology clinics, and statistical centers. Modern R&D efforts hunt for creams and ointments that deliver the molecule deeper, with lower risk of burning, itching, or rebound symptoms. Multi-center studies compare its performance against newer non-steroid treatments, checking not just relief but also patient well-being over months and years. Chemists continue to tinker with the base molecule, chasing versions that break down even more slowly in the skin or resist degradation from sunlight. New vehicle formulations—gels, foams, and sprays—aim to make dosing more precise. Patient feedback guides this process. Research teams, now more aware of the patient voice, have expanded clinical trial criteria to include not just rash reduction but also quality of life and treatment satisfaction.
Hydrocortisone-17-Butyrate carries a low toxicity profile for topical use, yet overuse or accidental ingestion spells trouble. The body, especially children and those with liver impairment, struggles to process excess steroids. Research in toxicology explores cutoff points—how much, for how long, in which population—before the risks outweigh the benefits. Animal models and case reports shape national guidelines. Poison control centers monitor trends in misuse, collecting reports to feed back into public health policy. There’s no option to ignore safety concerns; past tragedies from steroid overuse have left deep marks on medical guidelines.
Looking ahead, Hydrocortisone-17-Butyrate faces competition from newer molecules, non-steroidal creams, and biological agents. Still, its balance between safety, cost, and effectiveness keeps it relevant. Formulating new delivery systems—microencapsulation, patches, or slow-release foams—could extend its life in the clinic. Patient education remains a core challenge, since many still under- or over-apply topical steroids. Digital health tools, like smartphone reminders and AI-based symptom trackers, might link up with future versions of this medication to boost both patient adherence and doctor guidance. Researchers see potential partnerships between hydrocortisone esters and anti-inflammatory peptides, aiming for synergy in difficult-to-treat skin diseases. The story of Hydrocortisone-17-Butyrate, rooted in practical problem-solving and steady adaptation, looks far from over.
Hydrocortisone-17-butyrate finds its way into a lot of medicine cabinets, and for good reason. Many folks live with nagging eczema, psoriasis, or those outbreaks of dermatitis that never seem to quit. This medication, labeled as a corticosteroid, packs a punch against inflammation, redness, and the urge to scratch skin raw. It feels like magic, but there's a story behind why it offers relief.
I grew up in a family haunted by rashes and allergies, always chasing the next way to calm flare-ups. After a walk in tall grass, or even stress at school, a rash could pop up overnight. My mom's answer sat in a tube: hydrocortisone-17-butyrate, prescribed by our family doctor after over-the-counter hydrocortisone just didn’t cut it. The science behind this prescription? It brings down immune responses in the skin. Swelling fades, redness lightens, and the hot, unbearable itch disappears little by little. That small change can let a teenager sleep through the night or give comfort to a mechanic who can’t shake itchy hands after a day on the job.
This isn't like the mild hydrocortisone you see in drugstores. Hydrocortisone-17-butyrate is considered a “moderate strength” steroid, which means it can handle bigger problems but isn't quite as harsh as the ultra-potent stuff. Some stubborn patches barely respond to plain lotion; it takes something with more backbone. Studies show that this steroid goes deeper and works faster, yet most doctors will warn against slathering it everywhere. Overuse starts to thin the skin or make blood vessels show up like road maps.
Regulation matters here. In countries like the U.S. or those across Europe, prescription rules aim to protect the public. Too many people, chasing quick fixes, can harm themselves. Stories have surfaced about folks in other countries buying stronger creams over the counter and ending up with long-term skin issues. That’s a lesson on why stewardship by doctors is so important.
Treatments don’t stop at lotions. Anyone using hydrocortisone-17-butyrate has also been told to moisturize every single day, avoid harsh soaps, and pay attention to triggers. As a parent, I’ve learned that sometimes the best support comes from daily routines: short showers, humidifiers in the winter, or cotton clothes. Steroid creams form one line of defense, not the whole battle.
An honest conversation with a doctor makes a difference. Openly sharing what’s happening under your shirt sleeve or on your child’s cheeks can spare a lot of pain and frustration. Watching for side effects, like thin skin or odd bruises, keeps more serious risks in check. Research continues on safer alternatives. Smart minds are exploring non-steroid creams and lifestyle changes for folks who end up stuck on steroids for years.
So many people live with the scratch, burn, and embarrassment of skin issues. Hydrocortisone-17-butyrate gives a break from that daily struggle. Relief might start with a simple prescription, but it grows from knowledge, persistence, and honest care between patient and provider. A tube of cream can change a week, a job, or someone’s sleep. That’s the kind of everyday impact worth paying attention to and learning more about.
I’ve watched people underestimate prescription skin creams. They think applying more will fix the rash faster, they rub it in wherever it feels itchy, and sometimes they stop as soon as the skin “looks” better. The trouble is, Hydrocortisone-17-butyrate can backfire when it’s used the wrong way. Occasionally, patients land with thinning skin, stretchmarks, and “steroid-induced” trouble that takes even longer to fix. So, rubbing it in without a plan isn’t smart.
Pharmacies hand out finger-tip units as a guideline – cover about a hand-sized patch with a cream ribbon from the tip of your index finger to the first crease. This kind of steroid packs a punch. Smearing too much on gives you no benefit. I learned that from a pediatrician friend – she would caution parents to dab gently and spread a thin layer over the sore patch. And skip any broken skin or open wounds. If it stings or burns, stop right there and check with your doctor.
What a lot of folks gloss over: clean skin gets you better results. Grimy hands and dirty skin trap bacteria and trigger even more rashes. Just soap and water works fine—no scrubbing needed. I kept a little travel bottle of gentle cleanser for my own eczema flares, because even traces of dirt or makeup made the itching worse after applying any steroid.
Hydrocortisone-17-butyrate isn’t for the face unless a professional says so. This steroid is stronger than the over-the-counter stuff. Eyes and mouth areas need milder options, since powerful creams here raise risk of thinning and other side effects. For kids, or anyone with thin skin, doctors will suggest how many days to use it—with clear rules to stop or reduce frequency once the rash calms.
It’s always tempting to keep using something once it starts working, or to save leftovers for later flares. I used to wonder if a single missed day could make my rash roar back. Turns out, applying longer than advised causes more problems, especially in tricky spots like armpits, groin, or eyelids. Follow the timeline on the prescription, and if you see no results after the suggested period, don’t just keep going—let your doctor know.
Facts matter—reports show long-term misuse of topical steroids like hydrocortisone-17-butyrate leads to visible skin problems: lighter patches, paper-thin texture, swollen capillaries. If a cream stops helping or makes the skin feel odd, get medical input. I keep photos of my own skin flares so I can show changes to my healthcare provider, since subtle side effects are easier to spot with a weekly snapshot.
Anyone managing eczema, psoriasis, or allergic rashes will do better with a direct line to their care team. Keep notes about when you start the treatment, what the skin looks like, and whether the sensation changes with each application. Hydrocortisone-17-butyrate isn't a cure-all; it's one piece of the puzzle. Moisturize daily, avoid scratching, and protect affected patches from sun or harsh products. Small steps build up to better long-term results than rushing or misusing a strong medication.
Many folks turn to topical steroids for skin issues like eczema, psoriasis, or allergic rashes. Hydrocortisone-17-Butyrate belongs in this family, offering relief from itching and inflammation. People often underestimate the side effects that can come with these creams or ointments just because they apply them on the skin. That sense of safety can make things tricky, especially if you use such medications for a longer period or on sensitive skin.
After using Hydrocortisone-17-Butyrate for more than a few days, redness or a burning sensation sometimes crops up. Itching can oddly become worse right after application. Thin skin develops easily, especially on the face or in areas where the skin folds, like armpits and behind the knees. Using it on children’s skin, which is already delicate, can ramp up these effects.
The skin might also bruise more. Hair in the treated area can sprout faster or thicker. Lightening of skin color occasionally pops up, leading to uneven patches. In my own practice, I’ve seen patients show up with stretch marks that didn’t exist before. These marks don’t fade once they appear, which can be disappointing for people hoping for quick fixes.
Long-term use often affects the skin’s natural defenses. Fungal and bacterial infections can get a foothold. Pimples or pus-filled bumps sometimes show up, especially if the cream gets used on the face. I remember speaking with a patient who kept applying Hydrocortisone-17-Butyrate to clear up spots, not realizing it was making things worse. Steroids weaken the skin’s barrier, and suddenly, a small problem turns into a stubborn infection.
Most don’t expect what goes on below the surface. Large amounts or use over wide areas raise the risk of steroid getting into the bloodstream. Signs of this are hard to spot at first. One may notice sluggishness, weight gain, swelling in hands or feet, or mood swings. Children are especially sensitive to these effects, such as slowed growth. Data from clinical studies show that children who use strong topical steroids can experience measurable drops in the production of their own cortisol hormone, which comes from the adrenal glands.
People need education around these risks before they start therapy. For skin problems that don’t clear after a week of using Hydrocortisone-17-Butyrate, a doctor visit makes sense. Short bursts of treatment work best. Doctors usually recommend using steroid creams only on problem spots, not healthy skin, and never under airtight dressings unless specifically told. My patients get reminders to use gentle cleansers, steer clear of triggers that make skin flare up, and moisturize regularly to reduce the need for more steroids down the line.
Tracking changes with photos or a journal can help spot problems sooner. Pharmacists and nurses play a key role in counseling people picking up these prescriptions. A system that supports those with chronic skin problems—and gives them the tools to make safe choices—keeps complications at bay without taking away the benefits Hydrocortisone-17-Butyrate can offer when used correctly.
Seeing a child struggle with a persistent rash, eczema, or skin allergy can push parents and caregivers to seek relief. In pharmacies, hydrocortisone-17-butyrate cream often pops up as a suggested solution. This medicine, a corticosteroid, steps in to calm redness, itching, and swelling. At the same time, many parents worry about putting steroids on young, sensitive skin. I’ve been down this road as a parent, balancing expert advice, internet myths, and the genuine fear about harmful side effects.
Doctors prescribe hydrocortisone-17-butyrate to children for eczema flare-ups or stubborn skin irritation. The FDA classifies it as a medium-potency steroid, not the mildest but also not the strongest. This distinction means more power to control symptoms, but more risks if used carelessly. Children have thinner skin than adults. This allows medicines to soak in faster, sometimes leading to stronger effects and greater side effects, like stunted growth or thinner skin after long-term use.
Over the past decades, researchers tracked both the risks and benefits. As far back as the ’80s, studies showed short bursts of this medicine—just a few days—brought quick, clear results with little harm. Children using it under a doctor’s supervision avoided the problems seen when families tried stronger steroids or used them for weeks on end. Most harmful outcomes happened only after reckless applications, missing medical guidance, or ignoring the “small amount, short time” rule.
Pharmacists and dermatologists keep pulse on which topical steroids match children’s health best. The American Academy of Dermatology guides parents to always loop in a doctor before starting something like hydrocortisone-17-butyrate. The doctors I’ve spoken with treat this medicine as a “rescue tool” for tough outbreaks, not a daily moisturizer or a routine fix. Dangerous patterns emerge only where uncertainty leads caregivers to double applications, slather large patches daily, or skip follow-ups.
In my experience, asking plenty of questions at the pediatrician’s office brings more confidence. Good doctors walk parents through precise amounts—think fingertip units, not handfuls—and set strict calendars for use. They also encourage parents to keep cream away from sensitive areas like faces or diaper zones unless truly necessary. Doctors prioritize non-medicated moisturizers, gentle cleansers, and allergy control steps as the real long-term treatment plan.
Success with hydrocortisone-17-butyrate hinges on education. Busy parents push for quick fixes; overwhelmed by the discomfort and sleepless nights. A clear treatment plan stops this cycle. Pediatricians stress the importance of regular check-ins and quick pivots if creams cause stinging, color change, or infection. A 2021 review from the British Journal of Dermatology reaffirmed that strict instructions keep topical steroids safe—even for young children.
Practical changes at home play a bigger role than medicine alone. Daily bath routines with lukewarm water, fragrance-free creams straight after baths, and avoiding triggers like harsh fabrics can prevent wild flare-ups. Parents who keep open lines of communication with their healthcare providers spot problems early and adjust routines fast.
Children deserve quick relief from itchy, burning skin, but they also deserve treatment safe enough for their developing bodies. Community trust—between families, doctors, and pharmacists—builds the safest space for using medicines like hydrocortisone-17-butyrate. Those closest to the child’s care learn to weigh risks, watch for side effects, and never hesitate to ask for help. For itchy skin, smart—not scared—use makes all the difference.
Doctors reach for hydrocortisone-17-butyrate to help patients beat stubborn skin problems like eczema, psoriasis, and dermatitis. This medicine doesn’t just cool down the redness or stop the itch. It dives deeper, calming the parts of the immune system that keep the flare going. You find lower-strength hydrocortisone creams at the drugstore without a prescription. The stronger forms, like hydrocortisone-17-butyrate, sit behind the counter and need a doctor’s approval.
As someone who has worked in pharmacy and watched folks deal with skin trouble, I see why this restriction matters. Hydrocortisone-17-butyrate means business. Turning it loose in the wild without backups—like lab tests and a thorough doctor’s exam—opens the door to misdiagnosis. People end up treating stubborn infections or rashes the wrong way or for too long. Fungal problems might get worse if steroid creams are used without clearing up the true cause. Acne spreads or thin, fragile skin appears, especially after a few weeks of unsupervised use. The risks pile up fast when this class of steroid lands in the wrong hands.
The Food and Drug Administration keeps a close watch. Prescription control for hydrocortisone-17-butyrate lines up with guidance from many medical boards, including the American Academy of Dermatology. These organizations gather safety reports and research. They know that even healthy adults see problems from daily application of medium-strength steroids without supervision. Children and seniors get hit even harder.
Access to proper care matters just as much as safety. Some argue that making these medicines available over the counter would save time and money. The truth is, a rash that doesn’t heal or an infection masked by steroid creams can lead to bigger issues: emergency room visits, hospital stays, or scarring. I’ve seen pharmacy customers try to bypass rules with leftovers or by purchasing products online from unregulated foreign sources, counting on luck or advice from strangers on message boards. That gamble rarely pays off.
Experts highlight the importance of having a healthcare provider check on you, even for something as common as eczema. Treatment works better with a diagnosis. Health professionals check for allergies, infections, and any drug interactions. They also remind patients not to cover large areas with strong topical steroids or to keep them away from the face unless told otherwise. These steps cut the risk of skin thinning, easy bruising, and trouble with hormone levels.
Digital healthcare keeps changing the landscape. Telemedicine makes it easier to show rashes to a dermatologist without driving across town. Pharmacies play a bigger role too, teaching patients how to use what they’re prescribed. If prescriptions feel like a burden, expanding virtual care and public health information can shorten the wait while keeping bad outcomes in check.
Most people won’t need hydrocortisone-17-butyrate for every rash or itch. Doctors look for safer, lower-strength alternates first. When something stronger fits the problem, the prescription keeps things safe so people heal and get back to living without extra worry.
| Names | |
| Preferred IUPAC name | butyl (11β)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-oate |
| Other names |
Hydrocortisone butyrate
Hydrocortisone-17-butyrate Hydrocortisone butanoate |
| Pronunciation | /haɪˌdrəʊˌkɔːtɪˌsoʊn ˈsɛvənˈtiːn ˈbjuː.tɪ.reɪt/ |
| Preferred IUPAC name | (11β)-11,17,21-Trihydroxypregn-4-ene-3,20-dione 17-butanoate |
| Other names |
Hydrocortisone butyrate
Hydrocortisone 17-butyrate Hydrocortisone butanoate |
| Pronunciation | /haɪ.drəʊˈkɔː.tɪ.səʊn ˌsɛv.ənˈtiːn ˈbjuː.tɪ.reɪt/ |
| Identifiers | |
| CAS Number | 13609-67-1 |
| Beilstein Reference | 2889159 |
| ChEBI | CHEBI:31648 |
| ChEMBL | CHEMBL1200506 |
| ChemSpider | 14239512 |
| DrugBank | DB14640 |
| ECHA InfoCard | 100.248.183 |
| EC Number | “Hydrocortisone-17-Butyrate” does not have a distinct EC Number assigned. |
| Gmelin Reference | 87539 |
| KEGG | C14425 |
| MeSH | D006786 |
| PubChem CID | 160864 |
| RTECS number | WI9625000 |
| UNII | 2H11A8T9E7 |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID4057001 |
| CAS Number | 13609-67-1 |
| 3D model (JSmol) | `/JSmol/GL/mol/Hydrocortisone_17_butyrate.mol` |
| Beilstein Reference | 3593382 |
| ChEBI | CHEBI:31605 |
| ChEMBL | CHEMBL1201001 |
| ChemSpider | 10959056 |
| DrugBank | DB00547 |
| ECHA InfoCard | ECHA InfoCard: 1000048-51-2 |
| EC Number | EC 200-614-9 |
| Gmelin Reference | 112624 |
| KEGG | C14351 |
| MeSH | D017367 |
| PubChem CID | 6917895 |
| RTECS number | WI6137500 |
| UNII | 16G88C16PU |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID3094374 |
| Properties | |
| Chemical formula | C25H36O6 |
| Molar mass | 454.582 g/mol |
| Appearance | White to almost white crystalline powder |
| Odor | Odorless |
| Density | 1.17 g/cm3 |
| Solubility in water | Slightly soluble in water |
| log P | 2.2 |
| Acidity (pKa) | 12.59 |
| Basicity (pKb) | 6.48 |
| Refractive index (nD) | 1.4900 |
| Viscosity | Viscosity: 600 - 1200 cps |
| Dipole moment | 3.42 D |
| Chemical formula | C25H36O6 |
| Molar mass | 440.574 g/mol |
| Appearance | white to almost white crystalline powder |
| Odor | Odorless |
| Density | 1.12 g/cm3 |
| Solubility in water | Insoluble in water |
| log P | 1.78 |
| Acidity (pKa) | 12.68 |
| Basicity (pKb) | 12.53 |
| Refractive index (nD) | 1.514 |
| Viscosity | Viscosity: 600 - 1000 mPa.s |
| Dipole moment | 8.45 D |
| Pharmacology | |
| ATC code | D07AB05 |
| ATC code | D07AB05 |
| Hazards | |
| Main hazards | May cause skin irritation; may cause eye irritation; harmful if swallowed |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | Keep container tightly closed. Store in a cool, dry place. Avoid contact with eyes, skin, and clothing. Wash thoroughly after handling. Use only with adequate ventilation. If swallowed, get medical help immediately. Keep out of reach of children. |
| Flash point | > 230.7 °C |
| Lethal dose or concentration | LD₅₀ (Rat, oral): > 5,000 mg/kg |
| LD50 (median dose) | LD50 (median dose): 2000 mg/kg (Rat, oral) |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 0.01% |
| IDLH (Immediate danger) | Not established |
| Main hazards | Causes serious eye irritation. |
| GHS labelling | GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Precautionary statements | Keep out of reach of children. For external use only. Avoid contact with eyes. Do not use on broken or infected skin unless directed by a physician. If irritation develops, discontinue use and consult a healthcare professional. Use only as directed. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | 188.3°C |
| Lethal dose or concentration | LD50 (oral, rat): >4000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral, rat: 3851 mg/kg |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.04% |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Hydrocortisone
Hydrocortisone acetate Hydrocortisone buteprate Hydrocortisone-21-butyrate Cortisone Prednisolone Betamethasone Dexamethasone |
| Related compounds |
Corticosteroid
Hydrocortisone Hydrocortisone acetate Hydrocortisone buteprate Hydrocortisone valerate Prednisolone Methylprednisolone |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 367.2 J·mol⁻¹·K⁻¹ |
Providing high-quality chemical products and logistics solutions for global trade partners.
